Taha Ahmed, Mohammedzein Assad, Kimbugwe John, Carthel Kade, Brabham David
Department of Internal Medicine, Deaconess Hospital, Evansville, Indiana.
Department of Internal Medicine, Texas Tech University Health Sciences Center, Amarillo, Texas.
JACC Case Rep. 2019 Nov 6;1(4):622-625. doi: 10.1016/j.jaccas.2019.09.009. eCollection 2019 Dec.
Due to the scarcity of data, Impella RP is not approved for acute right ventricular failure caused by massive pulmonary embolism. We describe here the successful use of Impella RP in acute right ventricular failure caused by massive pulmonary embolism to highlight its promising outcome in such an indication. ().
由于数据稀缺,Impella RP未被批准用于治疗由大面积肺栓塞引起的急性右心室衰竭。我们在此描述了Impella RP在大面积肺栓塞所致急性右心室衰竭中的成功应用,以突出其在该适应症中的良好疗效。()